Literature DB >> 22612156

MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene.

Eric M McDade1, Bradley F Boeve, Julie A Fields, Neeraj Kumar, Rosa Rademakers, Matt C Baker, Bsc David S Knopman, Ronald C Petersen, Clifford R Jack, Kejal Kantarci.   

Abstract

To evaluate the proton magnetic resonance (MR) spectroscopy ((1) H MRS) changes in carriers of a novel octapeptide repeat insertion in the prion protein gene (PRNP) and family history of frontotemporal dementia with ataxia. Four at-risk mutation carriers and 13 controls were compared using single voxel, short TE, (1) H MRS from the posterior cingulate gyrus. The mutation carriers had an increased choline/creatine, P = .003 and increased myoinositol/creatine ratio, P = .003. (1) H MRS identified differences in markers of glial activity and choline metabolism in pre- and early-symptomatic carriers of a novel PRNP gene octapeptide insertion. These findings expand the possible diagnostic utility of (1) H MRS in familial prion disorders.
Copyright © 2012 by the American Society of Neuroimaging.

Entities:  

Keywords:  MRI; MRS; familial prion disorders; frontotemporal dementia

Mesh:

Substances:

Year:  2012        PMID: 22612156      PMCID: PMC3480551          DOI: 10.1111/j.1552-6569.2012.00717.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  19 in total

1.  Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis.

Authors:  A Ebel; B J Soher; A A Maudsley
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

2.  Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene.

Authors:  Neeraj Kumar; Bradley F Boeve; Brendon P Boot; Carolyn F Orr; Joseph Duffy; Bryan K Woodruff; Anil K Nair; Jay Ellison; Karen Kuntz; Kejal Kantarci; Clifford R Jack; Barbara F Westmoreland; Julie A Fields; Matthew Baker; Rosa Rademakers; Joseph E Parisi; Dennis W Dickson
Journal:  Arch Neurol       Date:  2011-09

3.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease.

Authors:  H G Pandya; S C Coley; I D Wilkinson; P D Griffiths
Journal:  Clin Radiol       Date:  2003-02       Impact factor: 2.350

5.  Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

6.  Automated single-voxel proton MRS: technical development and multisite verification.

Authors:  P G Webb; N Sailasuta; S J Kohler; T Raidy; R A Moats; R E Hurd
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

7.  (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

Authors:  M Catani; A Cherubini; R Howard; R Tarducci; G P Pelliccioli; M Piccirilli; G Gobbi; U Senin; P Mecocci
Journal:  Neuroreport       Date:  2001-08-08       Impact factor: 1.837

8.  1H MR spectroscopy in common dementias.

Authors:  K Kantarci; R C Petersen; B F Boeve; D S Knopman; D F Tang-Wai; P C O'Brien; S D Weigand; S D Edland; G E Smith; R J Ivnik; T J Ferman; E G Tangalos; C R Jack
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

9.  Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy.

Authors:  A D Waldman; R J Cordery; D G MacManus; A Godbolt; J Collinge; M N Rossor
Journal:  Neuroradiology       Date:  2006-04-06       Impact factor: 2.804

10.  MRS shows abnormalities before symptoms in familial Alzheimer disease.

Authors:  A K Godbolt; A D Waldman; D G MacManus; J M Schott; C Frost; L Cipolotti; N C Fox; M N Rossor
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

View more
  1 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.